Space Science Is Expected To Gain Emphasis Under New NASA Head

The end of the era of behemoth projects at the National Aeronautics and Space Administration may be at hand as Congress on March 31 confirmed a non-astronaut as the new administrator of an agency facing congressional funding cutbacks. Until his appointment, Daniel Goldin was vice president of TRW Inc.'s Space & Technology Group in Redondo Beach, Calif. TRW, a longtime NASA contractor, has been involved not in space shuttle-sized projects but in the smaller science of satellites, the Compton G

Written byScott Veggeberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Until his appointment, Daniel Goldin was vice president of TRW Inc.'s Space & Technology Group in Redondo Beach, Calif. TRW, a longtime NASA contractor, has been involved not in space shuttle-sized projects but in the smaller science of satellites, the Compton Gamma Ray Observatory, and the grinding of X-ray optics mirrors for astrophysical observations.

Unlike his predecessor, Richard Truly, a former shuttle pilot, Goldin has not flown in space. He began his career as a researcher 30 years ago at NASA's Lewis Research Center in Cleveland, where he worked on propulsion systems for interplanetary travel. According to media reports and sources in the Bush administration and the scientific community, Truly was removed to pave the way for changes at NASA that will make it less focused on large, manned adventures in space and toward doing space projects that are faster to complete and cheaper.

In an April 1 televised address, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies